Potent Cytotoxic Natural Flavonoids: The Limits of Perspective
-
Published:2019-04-26
Issue:46
Volume:24
Page:5555-5579
-
ISSN:1381-6128
-
Container-title:Current Pharmaceutical Design
-
language:en
-
Short-container-title:CPD
Author:
Taleghani Akram1, Tayarani-Najaran Zahra2
Affiliation:
1. Department of Chemistry, Faculty of Science, Gonbad Kavous University, Golestan Province, Gonbad Kavus, P.O. Box 163, Iran 2. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract
Background:Besides the numerous biologic and pharmacologic functions in the human body that act as potent antioxidants, flavonoids (flavones, flavanones, flavonols, flavanols and isoflavones) are noted as cancer preventive or therapeutic agents.Methods:This review summarizes the published data using PubMed, Science Direct, and Scopus.Results:In this context, recognition and introduction of the most active cytotoxic flavonoids as promising agents for cancer therapy gives insight for further evaluations. However, there are some critical points that may affect the entering of flavonoids as active cytotoxic phytochemicals in the clinical phase. Issues such as the abundance of active species in nature, the methods of extraction and purification, solubility, pharmacokinetic profile, presence of the chiral moieties, method of synthesis, and structure modification may limit the entry of a selected compound for use in humans. Although plenty of basic evidence exists for cytotoxic/antitumor activity of the versatility of flavonoids for entry into clinical trials, the above-mentioned concerns must be considered.Conclusion:This review is an effort to introduce cytotoxic natural flavonoids (IC50< 10 µM) that may have the potential to be used against various tumor cells. Also, active constituents, molecular mechanisms, and related clinical trials have been discussed as well as the limitations and challenges of using flavonoids in clinic.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Reference186 articles.
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Int J Cancer, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008., 2010, 127, 2893-2917, 2. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Ann Oncol, Cancer incidence and mortality in Iran., 2008, 20, 556-563, 3. Newman DJ, Cragg GM. J Nat Prod, Natural products as sources of new drugs over the 30 years from 1981 to 2010., 2012, 75, 311-335, 4. Pandey AK. Natl Acad Sci Lett, Anti-staphylococcal activity of a pan-tropical aggressive and obnoxious weed Parthenium histerophorus: an in vitro study., 2007, 30, 383-, 5. Cook N, Samman S. J Nutr Biochem, Flavonoids—chemistry, metabolism, cardioprotective effects, and dietary sources., 1996, 7, 66-76,
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|